Current Pharmaceutical Biotechnology

Editorial [Hot Topic: Novel High Through-put Approach and Molecular Modelling in Drug Discovery from Natural Products and Clinical Implications]
pp. 1631-1631(1)
Author: Guang Li, Chun

In Silico Search for Drug Targets of Natural Compounds
pp. 1632-1639(8)
Author: Yao, Lixia

Pharmacophore, QSAR, and Binding Mode Studies of Substrates of Human Cytochrome P450 2D6 (CYP2D6) Using Molecular Docking and Virtual Mutations and an Application to Chinese Herbal Medicine Screening
pp. 1640-1704(65)
Authors: Mo, Sui-Lin; Liu, Wei-Feng; Li, Chun-Guang; Zhou, Zhi-Wei; Luo, Hai-Bin; Chew, Helen; Liang, Jun; Zhou, Shu-Feng

Integrated Analysis on the Physicochemical Properties of Dihydropyridine Calcium Channel Blockers in Grapefruit Juice Interactions
pp. 1705-1717(13)
Authors: Uesawa, Yoshihiro; Takeuchi, Takahiro; Mohri, Kiminori

Herb-Drug Interactions: Methods to Identify Potential Influence of Genetic Variations in Genes Encoding Drug Metabolizing Enzymes and Drug Transporters
pp. 1718-1730(13)
Authors: Hu, M.; Q. Wang, D.; J. Xiao, Y.; W. L. Mak, V.; Tomlinson, B.

Editorial [Hot Topic: Oncolytic viruses]
pp. 1731-1731(1)
Author: Jia, William

Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
pp. 1732-1741(10)
Authors: Msaouel, P.; D. Iankov, I.; Dispenzieri, A.; Galanis, E.

Pro-Oncogenic Cell Signaling Machinery as a Target for Oncolytic Viruses
pp. 1742-1749(8)
Authors: Borrego-Diaz, Emma; Mathew, Rajesh; Hawkinson, Dana; Esfandyari, Tuba; Liu, Zhengian; W Lee, Patrick; Farassati, Faris

Oncolytic Viruses for Induction of Anti-Tumor Immunity
pp. 1750-1760(11)
Authors: W. Tong, Alex; Senzer, Neil; Cerullo, Vincenzo; Smyth Templeton, Nancy; Hemminki, Akseli; Nemunaitis, John

Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a Trend in Both Cancer Gene Therapy and Cancer Virotherapy
pp. 1761-1767(7)
Authors: Liu, Xin -Yuan; Li, Hua -Guang; Zhang, Kang -Jian; Gu, Jin -Fa

Targeted and Armed Oncolytic Poxviruses for Cancer: the Lead Example of JX-594
pp. 1768-1772(5)
Authors: J. Breitbach, Caroline; H. Thorne, Steve; C. Bell, John; H. Kirn, David

Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine
pp. 1773-1785(13)
Authors: Li, Qi-Xiang; Liu, Guohong; Zhang, Xiaoliu

Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers
pp. 1786-1794(9)
Authors: Wong, Jennifer; Lee, Cleo; Zhang, Kevin; S. Rennie, Paul; Jia, William

The Molecular Basis of Herpesviruses as Oncolytic Agents
pp. 1795-1803(9)
Authors: Menotti, Laura; Campadelli-Fiume, Gabriella; Nanni, Patrizia; Luigi Lollini, Pier; De Giovanni, Carla

Mining the Adenovirus "Virome" for Systemic Oncolytics
pp. 1804-1808(5)
Authors: A. Barry, Michael; A. Weaver, Eric; Y. Chen, Christopher

Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
pp. 1809-1816(8)
Authors: Fujiwara, Toshiyoshi; Kagawa, Shunsuke; Tazawa, Hiroshi

Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
pp. 1817-1833(17)
Authors: Tusell Wennier, Sonia; Liu, Jia; McFadden, Grant

Recent Clinical Experience with Oncolytic Viruses
pp. 1834-1841(8)
Authors: G. Donnelly, O.; Errington-Mais, F.; Prestwich, R.; Harrington, K.; Pandha, H.; Vile, R.; A. Melcher, A.

Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
pp. 1842-1851(10)
Authors: Kaur, Balveen; Antonio Chiocca, E.; P. Cripe, Timothy

Clinical Development of Oncolytic Viruses in China
pp. 1852-1857(6)
Author: Liang, Min